Stock listing
TWSE:6949 PELL Bio-Med Technology Co Ltd (沛爾生醫*-創) 股價
Follow PELL Bio-Med Technology Co Ltd into a list and get an email when it puts out news.
Share price · TWSE:6949
$36.65 TWD -8.40 (-18.6%)
Close on Nov 20, 2026
- Day range
- $36.65 – $40.00 TWDNov 20, 2026
- Volume
- 4.77M sharesNov 20, 2026
- Market cap
- $48.05B TWDAt the close on Nov 20, 2026 · price × 1.31B shares outstanding
- 52-week range
- $34.75 – $1,490.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.35B TWDMedian day 3.88M shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:6949 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $36.65 | -8.40 | -18.6% | $40.00 | $40.00 | $36.65 | 4,768,599 | |
| $45.05 | -0.30 | -0.7% | $46.70 | $48.45 | $43.00 | 4,823,430 | |
| $45.35 | -4.15 | -8.4% | $44.95 | $50.90 | $44.70 | 14,994,906 | |
| $49.50 | +4.50 | +10.0% | $49.50 | $49.50 | $48.00 | 6,202,983 | |
| $45.00 | +4.05 | +9.9% | $41.80 | $45.00 | $41.45 | 5,593,543 | |
| $40.95 | -3.80 | -8.5% | $49.20 | $49.20 | $40.55 | 23,707,219 | |
| $44.75 | +3.20 | +7.7% | $41.05 | $44.80 | $41.05 | 4,283,589 | |
| $41.55 | +1.50 | +3.7% | $42.05 | $42.25 | $39.85 | 5,376,104 | |
| $40.05 | +2.50 | +6.7% | $37.60 | $41.30 | $37.60 | 2,174,975 | |
| $37.55 | -1.05 | -2.7% | $35.55 | $37.90 | $35.25 | 2,903,043 | |
| $38.60 | -0.85 | -2.2% | $39.40 | $41.90 | $37.80 | 3,828,383 | |
| $39.45 | +0.25 | +0.6% | $39.30 | $39.75 | $37.05 | 2,252,725 | |
| $39.20 | -1.65 | -4.0% | $40.55 | $41.00 | $39.20 | 2,048,719 | |
| $40.85 | +1.80 | +4.6% | $38.10 | $41.65 | $38.10 | 2,119,257 | |
| $39.05 | -1.75 | -4.3% | $40.05 | $40.45 | $37.80 | 2,455,555 | |
| $40.80 | +1.15 | +2.9% | $40.00 | $41.50 | $39.50 | 2,954,244 | |
| $39.65 | +0.10 | +0.3% | $39.55 | $40.80 | $39.35 | 1,749,138 | |
| $39.55 | +1.85 | +4.9% | $38.70 | $41.45 | $38.45 | 3,661,662 | |
| $37.70 | 0.00 | 0.0% | $37.70 | $37.70 | $37.70 | 0 | |
| $37.70 | -1.40 | -3.6% | $39.35 | $39.85 | $37.60 | 1,720,641 | |
| $39.10 | +1.90 | +5.1% | $40.25 | $40.90 | $38.20 | 7,368,020 | |
| $37.20 | +1.30 | +3.6% | $36.00 | $39.45 | $34.75 | 7,057,261 | |
| $35.90 | -3.00 | -7.7% | $39.30 | $39.30 | $35.60 | 5,402,283 | |
| $38.90 | -0.10 | -0.3% | $39.45 | $39.80 | $38.10 | 2,939,300 | |
| $39.00 | -0.40 | -1.0% | $40.00 | $40.95 | $38.40 | 3,954,938 | |
| $39.40 | -2.65 | -6.3% | $42.00 | $42.00 | $38.00 | 16,638,650 | |
| $42.05 | -4.65 | -10.0% | $45.30 | $45.85 | $42.05 | 6,243,130 | |
| $46.70 | -0.15 | -0.3% | $46.85 | $47.50 | $45.30 | 3,326,100 | |
| $46.85 | +1.55 | +3.4% | $45.65 | $47.15 | $44.95 | 2,287,282 | |
| $45.30 | -1.45 | -3.1% | $46.60 | $47.70 | $44.85 | 2,319,027 | |
| $46.75 | -0.85 | -1.8% | $47.95 | $48.90 | $46.65 | 1,848,201 | |
| $47.60 | +3.10 | +7.0% | $45.20 | $48.10 | $44.35 | 3,927,603 | |
| $44.50 | -4.90 | -9.9% | $48.85 | $49.20 | $44.50 | 13,887,439 | |
| $49.40 | -1.20 | -2.4% | $50.00 | $50.80 | $49.00 | 2,111,120 | |
| $50.60 | +1.40 | +2.8% | $49.50 | $51.50 | $49.35 | 2,953,550 | |
| $49.20 | -1.10 | -2.2% | $49.85 | $51.50 | $48.45 | 3,035,002 | |
| $50.30 | 0.00 | 0.0% | $49.10 | $50.30 | $49.10 | 2,648,460 | |
| $50.30 | -0.50 | -1.0% | $49.25 | $51.00 | $49.25 | 2,829,500 | |
| $50.80 | -3.00 | -5.6% | $53.00 | $53.80 | $50.60 | 3,585,286 | |
| $53.80 | -0.70 | -1.3% | $54.00 | $54.90 | $53.00 | 2,687,800 | |
| $54.50 | +0.10 | +0.2% | $54.50 | $58.50 | $53.20 | 8,209,800 | |
| $54.40 | +1.30 | +2.4% | $51.60 | $55.30 | $51.60 | 4,485,935 | |
| $53.10 | +1.70 | +3.3% | $50.50 | $53.30 | $50.00 | 4,256,112 | |
| $51.40 | -4.40 | -7.9% | $54.80 | $56.00 | $51.00 | 7,357,700 | |
| $55.80 | +2.80 | +5.3% | $50.00 | $56.90 | $48.25 | 7,757,200 | |
| $53.00 | -5.80 | -9.9% | $55.90 | $60.10 | $53.00 | 13,476,470 | |
| $58.80 | +3.90 | +7.1% | $56.80 | $60.30 | $55.40 | 25,963,175 | |
| $54.90 | -5.50 | -9.1% | $59.80 | $60.40 | $54.40 | 34,416,198 | |
| $60.40 | -6.70 | -10.0% | $60.40 | $62.70 | $60.40 | 18,467,625 | |
| $67.10 | -7.40 | -9.9% | $81.90 | $81.90 | $67.10 | 24,344,655 | |
| $74.50 | 0.00 | 0.0% | $74.50 | $74.50 | $74.50 | 0 | |
| $74.50 | 0.00 | 0.0% | $74.50 | $74.50 | $74.50 | 0 | |
| $74.50 | 0.00 | 0.0% | $74.50 | $74.50 | $74.50 | 0 | |
| $74.50 | -1,415.50 | -95.0% | $74.50 | $74.50 | $74.50 | 0 | |
| $1,490.00 | 0.00 | 0.0% | $1,490.00 | $1,490.00 | $1,490.00 | 0 | |
| $1,490.00 | 0.00 | 0.0% | $1,490.00 | $1,490.00 | $1,490.00 | 0 | |
| $1,490.00 | 0.00 | 0.0% | $1,490.00 | $1,490.00 | $1,490.00 | 0 | |
| $1,490.00 | +135.00 | +10.0% | $1,405.00 | $1,490.00 | $1,400.00 | 11,001,520 | |
| $1,355.00 | +120.00 | +9.7% | $1,250.00 | $1,355.00 | $1,225.00 | 19,141,000 | |
| $1,235.00 | +80.00 | +6.9% | $1,180.00 | $1,260.00 | $1,165.00 | 10,240,400 | |
| $1,155.00 | +30.00 | +2.7% | $1,140.00 | $1,190.00 | $1,140.00 | 5,006,800 | |
| $1,125.00 | +40.00 | +3.7% | $1,105.00 | $1,130.00 | $1,075.00 | 5,440,420 |
Splits
1 split · TWSE:6949 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 20-for-1 | Split |
- Ticker
- TWSE:6949
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TWSE
- Currency
- TWD
PELL Bio-Med Technology Co Ltd on 6ix
- Sector
- Health care
- Industry
- Biotechnology
Valuation
EV/sales 1,591× against a median of 15.5×: the highest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $46.01B TWD
- P/E
- Loss
- EV/sales
- 1,591×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 18.7×
- Gross margin
- −49.4%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| PELL Bio-Med Technology Co Ltd · TWSE:6949 | US$1.46B | US$1.40B | n/a | 1,591× | n/a | 18.7× | n/a | 0.1× | n/a |
| ABL Bio, Inc. · KRX:298380 | US$1.48B | US$1.35B | n/a | 52.7× | n/a | 11.5× | −229.4% | 0.0× | n/a |
| Alvotech · NASDAQ:ALVO | US$1.47B | US$2.78B | n/a | 5.7× | 31.4× | n/a | −36.5% | n/a | 0.90 |
| Mesoblast Limited · ASX:MSB | US$1.46B | US$1.42B | n/a | 82.4× | n/a | 2.4× | −593.9% | 0.2× | n/a |
| Voronoi, Inc. · KRX:310210 | US$1.44B | US$1.40B | n/a | n/a | n/a | 27.9× | n/a | 0.5× | n/a |
| Damora Therapeutics, Inc. · NASDAQ:DMRA | US$1.44B | US$910.0M | n/a | n/a | n/a | 2.9× | n/a | 0.0× | 0.88 |
| Vir Biotechnology, Inc. · NASDAQ:VIR | US$1.44B | US$1.07B | n/a | 3.5× | n/a | 1.6× | −61.0% | 0.1× | 1.82 |
| LigaChem Biosciences Inc. · KRX:141080 | US$1.43B | US$1.15B | n/a | 15.5× | n/a | 4.8× | −180.9% | 0.0× | n/a |
| Kailera Therapeutics, Inc. · NASDAQ:KLRA | US$1.43B | US$539.5M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | 1.28 |
| Sarepta Therapeutics, Inc. · NASDAQ:SRPT | US$1.43B | US$1.41B | n/a | 0.7× | n/a | 0.9× | −5.9% | 0.6× | 1.70 |
| ADARx Pharmaceuticals, Inc. · NASDAQ:ADRX | US$1.42B | US$521.8M | n/a | 77.6× | n/a | 2.5× | n/a | 0.0× | n/a |
| Median of the others | US$1.44B | US$1.25B | 15.5× | 31.4× | 2.5× | −121.0% | 0.0× | 1.28 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 31.4M | 19.6M | 18.0M | 17.2M | 14.0M |
| Cost of revenue | 35.8M | 32.0M | 44.2M | 59.5M | 48.5M |
| Gross profit | -4.39M | -12.3M | -26.1M | -42.3M | -34.5M |
| Research and development | 252.7M | 266.2M | 239.6M | 142.4M | 136.7M |
| Selling, general and administrative | 201.5M | 121.0M | 124.7M | 71.8M | 39.7M |
| Operating income | -467.4M | -413.5M | -411.2M | -236.1M | -196.0M |
| Depreciation and amortization | 47.1M | 46.9M | 45.6M | 31.0M | 30.2M |
| EBITDA | -420.2M | -366.6M | -365.6M | -205.1M | -165.8M |
| Interest expense | 2.04M | 2.26M | 2.56M | 1.36M | 1.52M |
| Income before tax | -452.7M | -395.1M | -401.2M | -231.3M | -189.0M |
| Income tax | 112.0K | 2.00K | -1.14M | -14.0K | |
| Net income | -423.9M | -389.4M | -398.8M | -230.1M | -189.0M |
| Earnings per share, basic | -0.36 | -0.34 | -0.43 | -0.29 | -0.28 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 306.7M | 427.4M | 167.7M | 172.4M | 115.8M |
| Short-term investments | 1.00B | 708.8M | 938.1M | 536.0M | |
| Receivables | 6.01M | 4.31M | 7.93M | 6.41M | 10.6M |
| Inventory | 6.62M | 6.18M | 3.76M | 4.58M | 4.24M |
| Current assets | 1.33B | 1.16B | 1.13B | 725.4M | 131.8M |
| Total assets | 2.11B | 1.74B | 1.42B | 1.04B | 393.9M |
| Accounts payable | 5.70M | 4.47M | 6.99M | 5.57M | 3.15M |
| Current liabilities | 309.0M | 321.4M | 89.3M | 57.2M | 44.2M |
| Total debt | 237.4M | 364.8M | 172.6M | 202.8M | 141.1M |
| Total liabilities | 418.3M | 458.6M | 236.8M | 229.8M | 169.0M |
| Shareholders' equity | 1.42B | 1.18B | 1.17B | 800.9M | 224.9M |
| Shares outstanding | 1.17B | 1.14B | 925.2M | 784.5M | 665.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | -281.3M | -260.1M | -180.0M | -155.7M | -108.5M |
| Capital spending | -227.6M | -264.0M | -16.5M | -8.49M | -14.5M |
| Free cash flow | -508.9M | -524.1M | -196.5M | -164.2M | -123.0M |
| Cash from investing | -497.1M | -95.5M | -419.6M | -536.0M | 83.9M |
| Cash from financing | 657.8M | 615.3M | 594.9M | 748.3M | -4.56M |
| Share buybacks | 0 | -800.0K | 0 | ||
| Change in cash | -120.7M | 259.7M | -4.73M | 56.6M | -29.2M |
Cap table
Built by 6ix from PELL Bio-Med Technology Co Ltd’s releases
- Common shares
- 1,311,000,000
- Fully diluted
- 1,311,000,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,311,000,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,311,000,000 |
Log in to ask 6ix AI your own questions about PELL Bio-Med Technology Co Ltd.